Mercury General Corporation
Mercury General Corporation (MCY) Financial Performance & Income Statement Overview
Analyze Mercury General Corporation (MCY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Mercury General Corporation (MCY) Income Statement & Financial Overview
Review Mercury General Corporation MCY income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.39B | $1.37B | $1.53B | $1.30B |
| Cost of Revenue | $7.19M | $245.65M | $86.86M | $81.70M |
| Gross Profit | -$7.19M | -$3.86B | $1.44B | $1.22B |
| Gross Profit Ratio | -$0.005 | -$2.83 | $0.94 | $0.94 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $7.20M | $0.00 | $3.90M |
| Operating Expenses | $135.11M | -$131.03M | $1.53B | $285.38M |
| Total Costs & Expenses | $142.30M | -$123.50M | $1.53B | -$1.22B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $7.19M | $7.54M | $7.72M | $7.80M |
| Depreciation & Amortization | $17.24M | $19.59M | $19.11M | $17.20M |
| EBITDA | -$125.05M | $143.09M | $313.89M | $18.40M |
| EBITDA Ratio | -$0.09 | $0.10 | $0.21 | $0.01 |
| Operating Income | -$142.30M | $131.03M | $294.78M | $82.90M |
| Operating Income Ratio | -$0.10 | $0.10 | $0.19 | $0.06 |
| Other Income/Expenses (Net) | $0.00 | $0.00 | -$7.72M | $156.80M |
| Income Before Tax | -$142.30M | $123.50M | $287.06M | $75.10M |
| Income Before Tax Ratio | -$0.10 | $0.09 | $0.19 | $0.06 |
| Income Tax Expense | -$33.97M | $22.43M | $56.21M | $12.53M |
| Net Income | -$108.33M | $101.07M | $230.86M | $62.57M |
| Net Income Ratio | -$0.08 | $0.07 | $0.15 | $0.05 |
| EPS | -$1.96 | $1.83 | $4.17 | $1.13 |
| Diluted EPS | -$1.96 | $1.82 | $4.17 | $1.13 |
| Weighted Avg Shares Outstanding | $55.39M | $55.38M | $55.37M | $55.37M |
| Weighted Avg Shares Outstanding (Diluted) | $55.39M | $55.38M | $55.38M | $55.38M |
Over the past four quarters, Mercury General Corporation demonstrated steady revenue growth, increasing from $1.30B in Q2 2024 to $1.39B in Q1 2025. Operating income reached -$142.30M in Q1 2025, maintaining a consistent -10% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$125.05M, reflecting operational efficiency. Net income dropped to -$108.33M, with EPS at -$1.96. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan